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Introduction
Modern conservation science frequently relies on genetic tools to manage imperiled populations threatened
by processes such as habitat fragmentation and infectious diseases. Translocation of individuals to restore genetic diversity (genetic rescue) is increasingly used to
manage vulnerable populations (Whiteley et al. 2015),
but it can swamp local adaptations and lead to outbreeding depression (Frankham et al. 2011). Thus, genetic
management is context dependent and needs evaluation
across multiple generations (Fitzpatrick et al. 2020). Genomic studies can help evaluate the extent to which
populations are locally adapted to assess the costs and
benefits of translocations. Predicting the long-term fitness effects of genetic interventions and their evolutionary consequences is a vital step in managing dwindling
populations threatened by emerging infectious diseases.
Multicellular organisms have a long evolutionary history with oncogenic phenomena. While some cancerprotection adaptations are very old and phylogenetically
well conserved, such as cancer-suppression mechanisms

(Nunney 2013), others are species specific and shaped
by ecological processes and life-history traits (Ujvari et al.
2016). An increasing number of infectious cancers, virus
associated and directly transmissible, are occurring in terrestrial and aquatic environments (Hamede et al. 2020).
Thus, cancer is nowadays regarded as a disease of conservation concern (McAloose & Newton 2009), particularly for threatened wildlife (Hamede at al. 2020). We
considered the Tasmanian devil (Sarcophilus harrisii)
and its transmissible cancers as a model to examine the
integration of knowledge of host-pathogen evolutionary
interactions with wildlife disease management.
Devils have been afflicted by a transmissible cancer
(devil facial tumor disease [DFTD]) for at least 24 years
(Hawkins et al. 2006). The DFTD epidemic has caused
significant population declines (McCallum et al. 2009)
and led to the species’ listing as endangered (Hawkins
et al. 2009). In 2014 another, independently evolved,
transmissible cancer (devil facial tumor 2 [DFT2]) was
discovered in southeastern Tasmania (Pye et al. 2016b).
Translocations of captive or free-range devils sourced
from insurance populations with the aim of genetic
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tumor regressions appear to be affected by upregulation of putative tumor suppressor RASL11a, a gene not
expressed in human cancers (Margres et al. 2020). Allele frequencies in genomic regions associated with immune function and cancer changed significantly 4-6 generations after disease arrival (Epstein et al. 2016). These
changes occurred in 3 geographically separated populations and concurred with patterns of cessation of population decline at these sites. Moreover, a small number
of loci explains significant variation in case control (diseased vs. never diseased devils) and survival of infected
females (Margres et al. 2018b). These results provide evidence of rapid evolutionary responses, likely resulting
from extreme selection imposed by DFTD, and demonstrate that devils have sufficient genetic variation to respond and adapt to the DFTD epidemic, despite limited
genetic diversity (Bruniche-Olsen et al. 2014).
Applying Evolutionary Principles to Disease Management and
Devil Conservation

Figure 1. Two wild Tasmanian devils with DFTD (left)
and after natural tumor regression 3 months later
(right). Photos by Manuel Ruiz Aravena.
rescue (Grueber et al. 2019) are being tested, as are field
immunizations aimed at stimulating an adaptive immune
response (Pye et al. 2018). However, the epidemiological
and evolutionary consequences of introducing naïve individuals from insurance populations into diseased populations have not been evaluated comprehensively, thus,
current management is unlikely to prevent transmission.
Darwinian principles, host-pathogen coevolutionary theory, and the growing literature on ecological and evolutionary principles in oncology (Korolev et al. 2014)
suggest that silver bullets are unlikely to result in disease eradication. We considered evolutionary biology
and ecology of host-pathogen interactions to highlight
why the role of natural selection in host adaptations to
cancer should be considered in the management of this
species and other epizootics.
Adaptations to DFTD in Wild Devils
Early in the epizootic, DFTD caused localized population
declines of up to 90% (McCallum et al. 2009). Once tumors were detected, they were universally fatal. After 10
years, DFTD had reduced effects at the epidemic frontline (Hamede et al. 2012). Devils from populations in
northwestern Tasmania mounted immune responses to
DFTD, concomitant with natural tumor regressions and
recovery after infection (Pye et al. 2016a) (Fig 1). Devils with regressed tumors differed genetically from those
with nonregressed tumors (Margres et al. 2018a), and
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Evidence of devil evolutionary responses to DFTD
in geographically widespread locations (east, north,
and northwest) warrants a conservation strategy that
facilitates these beneficial adaptations. However, current
plans include translocating individuals sourced from
captive, DFTD-naïve populations into wild populations that have undergone generations of selection
for resistance or tolerance. Increasing the number of
susceptible individuals in diseased devil populations
is likely to fuel the epidemic by increasing infection
rates and potentially diluting or delaying selective
processes. The adaptive response of the devil to DFTD
involves interacting mechanisms and genes; thus, we
suggest captive-breeding programs incorporate wildsourced devils with genotypes that exhibit resistance
or tolerance to DFTD. Future studies should identify
evolutionary trade-offs associated with resistance or
tolerance to DFTD and their potential fitness effects.
To acquire herd immunity, over two-thirds of a population would need to be vaccinated, given the estimated
reproductive rate of DFTD (McCallum et al. 2009). Offspring of vaccinated devils would be susceptible and facilitate DFTD transmission. Although the development
of a vaccine is laudable, with potential future benefits
for management (Patchett & Woods 2019), premature
vaccination in the wild could have detrimental effects,
particularly if the vaccine cannot provide life-time immunity in 1 shot. Vaccines that let the host survive and
do not entirely prevent infection and spread can create ecological and epidemiological conditions that facilitate evolution and persistence of more virulent pathogen
strains (e.g., Gandon et al. 2001; Mackinnon et al. 2008).
Natural selection should remove highly lethal pathogens
if the death rate of hosts significantly reduces transmission. However, if vaccinations prolong host survival
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without precluding transmission, pathogen replication is
favored (Read et al. 2015), which may result in higher
prevalence and favor persistence of tumor strains that
might not be viable under natural selection. Therefore,
before widespread vaccination in the wild, experiments
to prove the prophylactic effect of vaccines and modeling of epidemic outcomes should be conducted.
Coexistence of devils and DFTD is the most likely
long-term enzootic outcome predicted by epidemiological models based solely on ecological processes (i.e., no
explicit genetic component) (Wells et al. 2019). Incorporating evolutionary change in epidemiological models will likely strengthen the likelihood of coexistence
of devils and DFTD without management. However, incorporating loss of genetic diversity may decrease the
likelihood of coexistence without further intervention.
One of the greatest difficulties, characterized by emerging infectious diseases and anthropogenic disturbance, is
to determine whether human intervention should be undertaken and whether its benefits outweigh the benefits
of facilitating recovery through natural selection. Interventions that enhance the prospects of devil recovery via
local adaptation should be prioritized, but relying solely
on evolution of natural adaptations to protect the species
is risky, particularly considering that the evolutionary interactions and epidemiological outcomes between DFTD
and DFT2 have not been evaluated fully. The emergent
DFT2 warrants further caution because observed adaptations to DFTD may not be relevant to DFT2. The cumulative effects of 2 transmissible cancers and other threats
need to be considered to balance the fitness effects of
locally adapted populations to transmissible tumors and
the loss of genetic diversity.
There is a fundamental conundrum between maximizing genetic diversity (genetic rescue) and allowing natural selection to progress (evolutionary rescue). In the
case of devils, where much empirical evidence shows
rapid evolution in response to DFTD in the wild and potential functional genetic changes have been identified,
we argue that management of adaptive genetic diversity
should be prioritized.
Captive-breeding programs to maintain genetic diversity are fundamental to protecting vulnerable populations. The case of Tasmanian devils and their cancer
epizootics illustrates the importance of developing crossdisciplinary approaches capable of timely assessments
of the ecoevolutionary processes between hosts and
pathogens and their consideration for management.
Therefore, we encourage managers and researchers to
engage in a scientific debate that integrates new knowledge and offers novel methods to assess the effects
of management on evolutionary and epidemiological
dynamics in the devil-DFTD-DFT2 system.
Evolutionary responses to pathogens with high mortality are not restricted to devils and DFTD. There is evidence of rapid evolutionary change in other host popula-
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tions subject to emerging wildlife diseases (e.g., frogs in
Central America exposed to chytrid fungus [Voyles et al.
2018]). Principles of evolutionary versus genetic rescue
are also relevant in other contexts, such as rapid environmental change (e.g., climate-adjusted provenancing), and
have direct implications for biodiversity conservation
and ecological restoration (Prober et al. 2015). Genomic
research is fine tuning and improving the capacity to
understand the genetic basis of adaptation. Balancing
the priorities of genetic rescue and evolutionary rescue
is a critical task for conservation. Modern genomic
methods, as exemplified by work on Tasmanian devils
and DFTD, provide new tools for integrated management
of populations threatened by diseases. For researchers
and managers, the fundamental principle should be as
espoused in the Hippocratic Oath, first, do no harm.
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